Clinical trial administration

Operation profile

Clinical trials are the result of promising new biotech and biomedical research. Once a new drug has been developed and tested on animals, the next step is clinical trials. Phase I clinical trials are conducted to confirm that a drug is not harmful. Phase II clinical trials measure the drug’s safety and effectiveness, while Phase III clinical trials further confirm a drug’s efficacy, compare it to alternate treatments, and evaluate side effects.

The representative operation modeled is a clinical trials management firm. As detailed in the following table, this operation is characterized by:

  • A leased office facility. (Because the representative operation is a management firm, hospital/clinical operations and related costs are not included in the operational model.)
  • A workforce consisting primarily of clinical trial administrators
  • Activities that mostly represent tax-eligible R&D activities.

The business is assumed to operate as a stand-alone profit center.
 

Summary of operating parameters

Industry: Clinical trial administration

Operation: Clinical trials management

Facilities requirements
Class A office space leased - ft2 (929 m2)
10,000

Other initial investment requirements
   Machinery and equipment - US $'000
--
   Office equipment - US $'000
$150
   R&D equipment - US $'000
--
   Inventory - US $'000
--
   Equity financing - % of project costs
85%

Workforce
   Management
3
   Sales and administration
9
   Dedicated product development
38
   Unskilled laborers
--
 
Total employees
50

Energy requirements
   Electricity: monthly consumption demand - kWh
25,000

Other annual operating characteristics
   Sales at full production - US $'000
$8,000
   Operating costs - % of sales
5%
   Investment in tax-eligible R&D - % of sales
58%

International results

International results are illustrated in the following chart. These results reflect the combined impact of 26 location-sensitive cost components applied to the modeled operation. Detailed results for these countries, by individual cost component, are available as a separate table.

City results

The following table profiles results for selected cities, by country, from among the 111 cities featured in this report. Results for all other cities included in the study can be found in the Results lookup section of this website.

Results for selected cities
Industry: Clinical trial administration
Operation: Clinical trials management
North America – selected cluster cities
Country and CityIndex & Rank1
CAEdmonton, AB70.317
 Montreal, QC69.013
 Quebec City, QC65.38
 Toronto, ON71.819
 Winnipeg, MB60.94
MXMexico City, DF62.45
 Monterrey, NL60.01
USBaton Rouge, LA90.956
 Boston, MA100.2106
 Indianapolis, IN91.463
 Minneapolis, MN93.383
 Philadelphia, PA99.5104
 Pittsburgh, PA94.689
 Providence, RI93.281
 Raleigh, NC92.376
 Salt Lake City, UT89.845
 Wilmington, DE96.9100
1  Rank among 111 featured cities.
 
 
 
International locations – all cities
Country and CityIndex & Rank1
AUAdelaide77.524
 Brisbane80.128
 Melbourne79.527
 Sydney81.329
FRMarseille70.318
 Paris74.021
GEBerlin90.047
 Frankfurt92.373
ITMilan81.830
 Rome78.826
JPOsaka88.735
 Tokyo91.970
NLAmsterdam77.825
 Rotterdam77.323
UKLondon90.551
 Manchester76.222
1  Rank among 111 featured cities.

 
Back to index

Download now

Competitive Alternatives 2016

Study reports

 

Corporate sponsors

Colliers

Colliers International

Link
MMK Consulting

MMK Consulting

Link

Contact KPMG

KPMG

Local KPMG contacts

See contacts